1. Cell growth inhibition, G₂M cell cycle arrest, and apoptosis induced by the novel compound Alternol in human gastric carcinoma cell line MGC803

   • Xia Liu
   • Jingze Wang
   • Changling Li

   PRECLINICAL STUDIES 10 July 2007 Pages: 505 - 517

   

2. Targeting telomerase activity by BIBR1532 as a therapeutic approach in germ cell tumors

   • Sandra Mueller
   • Ulrike Hartmann
   • Carsten Bokemeyer

   PRECLINICAL STUDIES 30 May 2007 Pages: 519 - 524

   

3. Pomolic acid-induced apoptosis in cells from patients with chronic myeloid leukemia exhibiting different drug resistance profile

   • F. C. Vasconcelos
   • C. R. Gattass
   • R. C. Maia

   PRECLINICAL STUDIES 23 May 2007 Pages: 525 - 533

   

4. Naphthylnitrobutadienes as pharmacologically active molecules: evaluation of the in vivo antitumour activity

   • Giovanni Petrillo
   • Carla Fenoglio
   • Maurizio Viale

   PRECLINICAL STUDIES 16 June 2007 Pages: 535 - 544

   

5. A phase II clinical trial of ZD1839 (Iressa™) in combination with docetaxel as first-line treatment in patients with advanced breast cancer

   • Sheri K. Dennison
   • Samuel A. Jacobs
   • Sandra M. Swain

   PHASE II STUDIES 12 June 2007 Pages: 545 - 551

   

6. A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret Hospital Phase II consortium

   • M. J. Mackenzie
   • D. Saltman
   • M. J. Moore

   PHASE II STUDIES 22 June 2007 Pages: 553 - 558

   

7. Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer

   • Elisabetta Campagnoli
   • Isabella Garassino
   • Raffaele Cavina

   PHASE II STUDIES 19 June 2007 Pages: 559 - 564

8. Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel

   • Tomasz M. Beer
   • Celestia S. Higano
   • Alison L. Hannah

   PHASE II STUDIES 07 July 2007 Pages: 565 - 570

9. Intravenous ATP infusions can be safely administered in the home setting: a study in pre-terminal cancer patients

   • Sandra Beijer
   • Eric A. R. Gielisse
   • Pieter C. Dagnelie

   PHASE III STUDIES Open access 05 September 2007 Pages: 571 - 579